Chasing the Miracles of Science
Sanofi is an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth
Every year Sanofi globally delivers over 2.1 billion healthcare solutions, helping make a difference in millions of lives all over the world. We’re present in over 60 countries, and our medicines and vaccines are available in more than 130 countries.
Present in India for nearly seven decades, we offer innovative solutions in preventive healthcare (vaccines) as well as therapies for diabetes, rare diseases and transplant needs.
Our Science…
Looking for medical and scientific content that's trusted, relevant, and curated for registered HCPs?
Pursue Progress. Discover Extraordinary.
Progress doesn’t happen without people—people from different backgrounds, in different locations, doing different roles, all united by one thing: a desire to make miracles. Better medications, better outcomes, better science.
Better is out there – and it starts with you. Join us in this journey to find better solutions for the people we help.
Media Releases
Sanofi’s breakthrough therapy Rezurock® approved in India for treating patients living with chronic graft-versus-host disease (cGVHD)
Announcement February 10, 2025
Sanofi Healthcare India Pvt. Limited announces receipt of marketing authorization for Rezurock® (Belumosudil Tablets) in India.
Sanofi receives marketing authorization for Beyfortus® in India to protect infants & children against Respiratory Syncytial Virus (RSV)
Announcement July 31, 2024
Sanofi (India) announced that on 10th June 2024 it has received marketing authorization approval from the Central Drugs Standard Control Organization (CDSCO) for Beyfortus in India.
Sanofi’s diabetes drug Soliqua® now available in India
Announcement April 25, 2024
Sanofi India Limited has launched its’ new diabetes drug Soliqua® after having received the marketing authorization from the Central Drugs Standard Control Organization (CDSCO) earlier last year.
Contact us
For seeking medical information, reporting adverse events and product complaints: 1800 22 2295 (toll-free) For other queries: 022-28032000
For medical information: medinfo.india@sanofi.com, customercare.chc@sanofi.com (Consumer healthcare products)
For reporting adverse events: PV.india@sanofi.com
For product complaints: ptcindia@sanofi.com
For other queries: Write here
Beware of Fraudsters
Beware of fraudsters who might intend to deceive you financially or otherwise by unauthorisedly using Sanofi’s name or logo and/or offering fake or counterfeit medicines; and/or by sharing fake apps, videos, games or other such assets. You are advised to immediately raise this before an appropriate cyber cell/police, should you face any such concern.
Few ways to recognize this:
The video/app/photo/game you view is not hosted on an official Sanofi channel (like @IndiaSanofi on Facebook or @Sanofi on Instagram or @IndiaSanofi on Twitter or @Sanofi on LinkedIn) The communication you may receive, appears unprofessional, containing poor grammar and/or typos Emails or other communication is not sent from a Sanofi address (please note that legitimate emails end only with a ‘@sanofi.com’ extension and procurement of company products is only through authorized Sanofi distributor channels) Inspite of a product shortage, if you are promised the product delivery at short notice, in exchange of an immediate online transfer or cash If you have any such concern, please write to us through the above channel.
All consumers or patients are advised to contact their doctor or healthcare professional for advice on medicines or any health matters/medical emergencies.
You can email or call us between 9 AM and 5 PM on any working day (we are closed on Saturday, Sunday and public holidays). Please select IVRS option 3 for reporting adverse events.